Granules India has announced the successful completion of its acquisition of Senn Chemicals AG, a Switzerland-based Contract Development and Manufacturing Organization (CDMO) with expertise in peptide development and manufacturing. The deal was executed through Granules’ wholly owned Indian subsidiary, Granules Peptides. The
Granules India Limited has announced the signing of an agreement to acquire Senn Chemicals AG, a Switzerland-based CDMO focused on peptide development and manufacturing. The deal is expected to close in the first half of 2025, subject to regulatory approvals. Senn Chemicals specialises
Granules is a Manufacturer/Innovator company operating in the pharmaceutical industry. Granules India Limited is a fast growing pharmaceutical company with world-class facilities for APIs, PFIs and Finished Dosages, serving customers in over 60 countries. We are committed to excellence in
Indian pharmaceutical company Granules has opened a new packaging facility in Virginia, United States, as part of its strategy to expand its global presence and meet growing demand for its products.
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
